跳轉至內容
Merck
全部照片(1)

Key Documents

42000001

Sigma-Aldrich

PRONOVA® UP LVG

low viscosity sodium alginate, viscosity 20-200 mPa.s, 1 %(20 °C)(low), guluronate monomer units ≥60 %

同義詞:

Ultra-Pure Low Viscosity Gel

登入查看組織和合約定價
全部照片(1)

About This Item

分類程式碼代碼:
12352201
NACRES:
NA.25

品質等級

100

形狀

powder

分子量

Mw 75-200 kDa (approximate)

成份

guluronate monomer units, ≥60%
G/M ratio, ≥1.5

雜質

≤100 CFU/g Total viable count
≤100 EU/g Endotoxins

pH值

5.5-8.5 (20 °C, 1% in water)

黏度

20-200 mPa.s, 1 %(20 °C) (
low)

一般說明

PRONOVA UP LVG is a low viscosity (20-200 mPas) sodium alginate where minimum 60% of the monomer units are guluronate.

應用

Examples of Pronova UltraPure Alginates applications include: encapsulation of living cells and therapeutic proteins for cell therapy medications, cryoprotectant, bone putty binder for tissue engineering, 3D bioprinting, foams and cell tissue scaffolds, hydrogels, advanced drug delivery and implants, wound management, and medical devices.

法律資訊

Product of Dupont Nutrition USA, Inc.
PRONOVA is a registered trademark of International N&H USA, Inc.

免責聲明

NOT FOR USE IN HUMANS

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

WGK 1

閃點（°F）

Not applicable

閃點（°C）

Not applicable

分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。

已經擁有該產品？

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

文章

Rational Design of ECMs Toward Cancer Immunotherapy

Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.

我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務